AbCellera Results Presentation Deck

Q3 2021 BUSINESS UPDATE COPYRIGHT © ABCELLERA 6 UNLOCKING INNOVATION FOR DRUG DEVELOPERS OF ALL SIZES Next-Gen Modalities Y IgGs, IgMs, IgAs single domain CAR-T Cell therapies Y Y bispecific antibodies radioisotope conjugates CNS-delivered antibodies moderna REGENERON QEQ Pfizer BILL MELINDA GATES foundation Ablynx A SANOT COMPANY Invetx MERCK Lilly gsk NOVARTIS igm DARPA EMPIRICO Autolus TACHYON GILEAD EVEREST MEDICINES SANOFI KODIAK DENALI angios Lyell teva

View entire presentation